📰 Nat Commun News
Page 2 - Nat Commun News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nat Commun. Real-time updates on events, politics, business and more.
February 21, 2024
Composite materials have revolutionized our industry, bringing outstanding performance to commonly used materials. However, designing these materials for maximum performance is not always intuitive.
February 9, 2024
Celebrating women's pivotal role in graphene research on the International Day of Women and Girls in Science. #WomenInScience #GrapheneResearch
January 25, 2024
Structured light enhances quantum communication by exploiting light's DoFs for high-dimensional, secure data transfer.
January 18, 2024
The use of machine learning has provided a significant boost to the field of materials discovery, and experts are using this advanced technique to discover various types of materials.
January 17, 2024
Doctors who were told about deaths and given planning prompts wrote fewer opioid scripts
January 10, 2024
<p>A breakthrough study led by <a href="https://www.texasheart.org/people/mehdi-razavi/">Dr. Mehdi Razavi</a>&nbsp;at&nbsp;<a href="https://www.texasheart.org">The Texas Heart Institute</a>&nbsp;(THI), in collaboration with a biomedical engineering team of&nbsp;<a href="https://www.utexas.edu/" target="_blank">The University of Texas at Austin</a>&nbsp;(UT Austin) Cockrell School of Engineering ...
December 19, 2023
About 3.2 million Americans have moved due to the mounting risk of flooding, the First Street Foundation (FSF), a nonprofit research group, said in
November 20, 2023
Doctoral Student (PhD) (m/f/d) job in Germany (DE) with University of Freiburg (Uni Freiburg). Apply Today.
October 25, 2023
New research suggests that solar power will be the dominant power source by 2050, "even without more ambitious climate policies"... Horst Schist!
September 21, 2023
MTNX-1700 (mTFF2-MSA) suppresses tumor growth and increases survival rates in preclinical colorectal cancer models mTNX-1700 shows single agent activity and additive effects in combination with anti-PD-1 mTNX-1700 targets myeloid-derived suppressor cells (MDSCs) in a novel mechanism to treat cancer CHATHAM, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today